4/A

PRIMARY DOCUMENT

Company: COLLEGIUM PHARMACEUTICAL, INC
Filed: January 22, 2021
Period of Report: January 19, 2021
Accession Number: 0001192482-21-000096

View Document ↗ View on SEC.gov ↗